Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, when NICE last approved a breast cancer medicine for routine use on the NHS through the technology appraisal process.

The National Institute for Health and Care Excellence (NICE) has confirmed that the last piece of technology appraisal guidance recommending a breast cancer drug was on gemcitabine for the treatment of metastatic breast cancer (TA116), published in January 2007.

A number of drugs for the treatment of breast cancer have been made available through the Cancer Drugs Fund since it was established in 2010. The Fund has now helped 95,000 people in accessing life-extending cancer drugs that would not otherwise have been available to them.